While I am convinced Anavex have/had more work to complete the analysis, I am becoming convinced that regulatory preparations are also running alongside changes to guidance and FDA approach to process and approvals.
I am very interested to learn what transpires over the coming weeks and months. If a P2b trial, hat off to Flash!